The number of successful injections associates with improved clinical effect in intralymphatic immunotherapy.

Keywords: allergy treament; immunotherapy and tolerance induction; immunotherapy clinical; intralymphatic immunotherapy EN allergy treament immunotherapy and tolerance induction immunotherapy clinical intralymphatic immunotherapy 1859 1861 3 06/18/21 20210601 NES 210601 Intralymphatic immunotherapy, ILIT, has emerged as a symptom-reducing immune treatment of allergic rhinoconjunctivitis as most studies find significant efficacy.1,2 In ILIT, a dose of allergen 100-fold lower than in SCIT is injected into a lymph node. In conclusion, the clinical response, but thankfully not safety, seems to depend on successful ILIT injections and low-quality injections must be acknowledged as a possible reason for treatment failure in ILIT. Allergy treament, immunotherapy and tolerance induction, immunotherapy clinical, intralymphatic immunotherapy. [Extracted from the article]